# Darifenacin

NDC: 16571-768
Generic name: Darifenacin
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20160919

FDA application: ANDA206743

## Active ingredients

- DARIFENACIN HYDROBROMIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16571-768"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16571-768
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2aa9544-0136-463d-a73b-1a299534446a